100th つないで、進む FRONTIERS IN LIFE SCIENCE

検索の使い方

Breast Cancer Tissue Array With Cancer Adjacent Breast Tissue As Control, Including TNM, Clinical Stage And Pathology Grade, 69 Cases/ 207 Cores|ヒト組織アレイ

掲載日情報：2015/08/14 現在Webページ番号：174476

ティッシューアレイドットコム /
TissueArray.Com LLC
[メーカー略称：USB]

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Breast Cancer Tissue Array With Cancer Adjacent Breast Tissue As Control, Including TNM, Clinical Stage And Pathology Grade, 69 Cases/ 207 Cores)をご紹介します。

※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。

カートに商品を
追加しました。

ヒト組織アレイの価格

[在庫・価格 ：2025年05月01日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
 納期 文献数
Breast cancer tissue array with cancer adjacent breast tissue as control, including TNM, clinical stage and patholog・・・
  • メーカーサイト
  • お問い合わせ
 2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • メーカーサイト
  • お問い合わせ
説明文
法規制等
保存条件 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして

[在庫・価格 ：2025年05月01日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Breast cancer tissue array with cancer adjacent breast tissue as control, including TNM, clinical stage and patholog・・・

文献数： 0

  • メーカーサイト
  • お問い合わせ

説明文
法規制等
保存条件 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして
  • メーカーサイト
  • お問い合わせ

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの特長

Microarray Panel: Breast carcinoma tissue microarray with cancer adjacent breast tissue, containing 60 cases of breast invasive ductal carcinoma from grade 1-3 and 9 cases of cancer adjacent breast tissue, triplicate cores per case
Cores: 207
Cases: 69
Layout: 16 cols × 13 rows
Core Diameter: 1 mm
Thickness: 5 µm
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 49 Breast Invasive ductal carcinoma 1 IIIA T3N1M0 Malignant
A2 2 F 49 Breast Invasive ductal carcinoma 1 IIIA T3N1M0 Malignant
A3 3 F 49 Breast Invasive ductal carcinoma 1 IIIA T3N1M0 Malignant
A4 4 F 46 Breast Invasive ductal carcinoma (sparse) – IIB T2N1M0 Malignant
A5 5 F 46 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
A6 6 F 46 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
A7 7 F 59 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A8 8 F 59 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A9 9 F 59 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A10 10 F 72 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
A11 11 F 72 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
A12 12 F 72 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
A13 13 F 42 Breast Invasive ductal carcinoma 1 IIA T2N0M0 Malignant
A14 14 F 42 Breast Invasive ductal carcinoma 1 IIA T2N0M0 Malignant
A15 15 F 42 Breast Invasive ductal carcinoma 1 IIA T2N0M0 Malignant
A16 16 F 40 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
B1 17 F 40 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
B2 18 F 40 Breast Invasive ductal carcinoma 1 IIB T2N1M0 Malignant
B3 19 F 54 Breast Invasive ductal carcinoma 2 IIIA T3N1M0 Malignant
B4 20 F 54 Breast Invasive ductal carcinoma 2 IIIA T3N1M0 Malignant
B5 21 F 54 Breast Invasive ductal carcinoma (fibrofatty tissue and blood vessel) – IIIA T3N1M0 Malignant
B6 22 F 55 Breast Invasive ductal carcinoma 1 IIIB T4N1M0 Malignant
B7 23 F 55 Breast Invasive ductal carcinoma (fibrous tissue and blood vessel) – IIIB T4N1M0 Malignant
B8 24 F 55 Breast Invasive ductal carcinoma (sparse) – IIIB T4N1M0 Malignant
B9 25 F 43 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
B10 26 F 43 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
B11 27 F 43 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
B12 28 F 41 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
B13 29 F 41 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
B14 30 F 41 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
B15 31 F 30 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
B16 32 F 30 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
C1 33 F 30 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
C2 34 F 45 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C3 35 F 45 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C4 36 F 45 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C5 37 F 47 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
C6 38 F 47 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
C7 39 F 47 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
C8 40 F 45 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
C9 41 F 45 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
C10 42 F 45 Breast Invasive ductal carcinoma 1 IIIA T2N2M0 Malignant
C11 43 F 38 Breast Invasive ductal carcinoma 2 IIB T3N0M0 Malignant
C12 44 F 38 Breast Invasive ductal carcinoma 2 IIB T3N0M0 Malignant
C13 45 F 38 Breast Invasive ductal carcinoma 2 IIB T3N0M0 Malignant
C14 46 F 48 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C15 47 F 48 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C16 48 F 48 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D1 49 F 54 Breast Invasive ductal carcinoma 1 IIA T2N0M0 Malignant
D2 50 F 54 Breast Invasive ductal carcinoma 1 IIA T2N0M0 Malignant
D3 51 F 54 Breast Invasive ductal carcinoma 1 IIA T2N0M0 Malignant
D4 52 F 45 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
D5 53 F 45 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
D6 54 F 45 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
D7 55 F 55 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D8 56 F 55 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D9 57 F 55 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D10 58 F 40 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
D11 59 F 40 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
D12 60 F 40 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
D13 61 F 54 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
D14 62 F 54 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
D15 63 F 54 Breast Invasive ductal carcinoma 2 IIIA T2N2M0 Malignant
D16 64 F 48 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
E1 65 F 48 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
E2 66 F 48 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
E3 67 F 53 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
E4 68 F 53 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
E5 69 F 53 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
E6 70 F 37 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
E7 71 F 37 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
E8 72 F 37 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
E9 73 F 52 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
E10 74 F 52 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
E11 75 F 52 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
E12 76 F 55 Breast Invasive ductal carcinoma with cataplasia 2 IIA T2N0M0 Malignant
E13 77 F 55 Breast Invasive ductal carcinoma with cataplasia 2 IIA T2N0M0 Malignant
E14 78 F 55 Breast Invasive ductal carcinoma with cataplasia 2 IIA T2N0M0 Malignant
E15 79 F 48 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
E16 80 F 48 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
F1 81 F 48 Breast Invasive ductal carcinoma 2 IIA T1N1M0 Malignant
F2 82 F 34 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F3 83 F 34 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F4 84 F 34 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F5 85 F 43 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F6 86 F 43 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F7 87 F 43 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F8 88 F 40 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F9 89 F 40 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F10 90 F 40 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
F11 91 F 50 Breast Invasive ductal carcinoma 3 IIIB T4N1M0 Malignant
F12 92 F 50 Breast Invasive ductal carcinoma 3 IIIB T4N1M0 Malignant
F13 93 F 50 Breast Invasive ductal carcinoma 3 IIIB T4N1M0 Malignant
F14 94 F 53 Breast Invasive ductal carcinoma (fibrous tissue, blood vessel and sparse gland) – IIIB T4N1M0 Malignant
F15 95 F 53 Breast Invasive ductal carcinoma (sparse) – IIIB T4N1M0 Malignant
F16 96 F 53 Breast Invasive ductal carcinoma with necrosis 2 IIIB T4N1M0 Malignant
G1 97 F 59 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
G2 98 F 59 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
G3 99 F 59 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
G4 100 F 42 Breast Invasive ductal carcinoma with cataplasis 2 IIA T2N0M0 Malignant
G5 101 F 42 Breast Invasive ductal carcinoma with cataplasis 2 IIA T2N0M0 Malignant
G6 102 F 42 Breast Invasive ductal carcinoma with cataplasis 2 IIA T2N0M0 Malignant
G7 103 F 52 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
G8 104 F 52 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
G9 105 F 52 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
G10 106 F 50 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
G11 107 F 50 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
G12 108 F 50 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
G13 109 F 50 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
G14 110 F 50 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
G15 111 F 50 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
G16 112 F 57 Breast Invasive ductal carcinoma (chronic inflammation of fibrous tissue and blood vessel) 2 IIIA T3N1M0 Malignant
H1 113 F 57 Breast Invasive ductal carcinoma (sparse) – IIIA T3N1M0 Malignant
H2 114 F 57 Breast Invasive ductal carcinoma (sparse) – IIIA T3N1M0 Malignant
H3 115 F 44 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
H4 116 F 44 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
H5 117 F 44 Breast Invasive ductal carcinoma 2 IIA T2N0M0 Malignant
H6 118 F 39 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
H7 119 F 39 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
H8 120 F 39 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
H9 121 F 58 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
H10 122 F 58 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
H11 123 F 58 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
H12 124 F 60 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
H13 125 F 60 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
H14 126 F 60 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
H15 127 F 52 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
H16 128 F 52 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
I1 129 F 52 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
I2 130 F 52 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
I3 131 F 52 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
I4 132 F 52 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
I5 133 F 52 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I6 134 F 52 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I7 135 F 52 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I8 136 F 62 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I9 137 F 62 Breast Invasive ductal carcinoma (sparse) 3 IIB T2N1M0 Malignant
I10 138 F 62 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I11 139 M 56 Breast Invasive ductal carcinoma 3 IIIA T2N2M0 Malignant
I12 140 M 56 Breast Invasive ductal carcinoma 3 IIIA T2N2M0 Malignant
I13 141 M 56 Breast Invasive ductal carcinoma 3 IIIA T2N2M0 Malignant
I14 142 F 54 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I15 143 F 54 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
I16 144 F 54 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
J1 145 F 37 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
J2 146 F 37 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
J3 147 F 37 Breast Invasive ductal carcinoma 2 IIB T2N1M0 Malignant
J4 148 F 56 Breast Invasive ductal carcinoma 3 I T1N0M0 Malignant
J5 149 F 56 Breast Invasive ductal carcinoma 3 I T1N0M0 Malignant
J6 150 F 56 Breast Invasive ductal carcinoma 3 I T1N0M0 Malignant
J7 151 F 44 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
J8 152 F 44 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
J9 153 F 44 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
J10 154 F 43 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
J11 155 F 43 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
J12 156 F 43 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
J13 157 F 62 Breast Invasive ductal carcinoma 3 I T1N0M0 Malignant
J14 158 F 62 Breast Invasive ductal carcinoma 3 I T1N0M0 Malignant
J15 159 F 62 Breast Invasive ductal carcinoma 3 I T1N0M0 Malignant
J16 160 F 59 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
K1 161 F 59 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
K2 162 F 59 Breast Invasive ductal carcinoma 3 IIA T2N0M0 Malignant
K3 163 F 52 Breast Invasive ductal carcinoma (sparse) 3 IIIA T3N2M0 Malignant
K4 164 F 52 Breast Invasive ductal carcinoma 3 IIIA T3N2M0 Malignant
K5 165 F 52 Breast Invasive ductal carcinoma 3 IIIA T3N2M0 Malignant
K6 166 F 53 Breast Invasive ductal carcinoma 3 IIIB T4N2M0 Malignant
K7 167 F 53 Breast Invasive ductal carcinoma 3 IIIB T4N2M0 Malignant
K8 168 F 53 Breast Invasive ductal carcinoma 3 IIIB T4N2M0 Malignant
K9 169 F 45 Breast Invasive ductal carcinoma 3 IIIA T3N1M0 Malignant
K10 170 F 45 Breast Invasive ductal carcinoma 3 IIIA T3N1M0 Malignant
K11 171 F 45 Breast Invasive ductal carcinoma 3 IIIA T3N1M0 Malignant
K12 172 F 51 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
K13 173 F 51 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
K14 174 F 51 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
K15 175 F 45 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
K16 176 F 45 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
L1 177 F 45 Breast Invasive ductal carcinoma 3 IIB T2N1M0 Malignant
L2 178 F 43 Breast Invasive ductal carcinoma 3 IIA T1N1M0 Malignant
L3 179 F 43 Breast Invasive ductal carcinoma 3 IIA T1N1M0 Malignant
L4 180 F 43 Breast Invasive ductal carcinoma 3 IIA T1N1M0 Malignant
L5 181 F 30 Breast Cancer adjacent breast tissue – – – NAT
L6 182 F 30 Breast Cancer adjacent breast tissue – – – NAT
L7 183 F 30 Breast Cancer adjacent breast tissue – – – NAT
L8 184 F 40 Breast Adenosis – – – NAT
L9 185 F 40 Breast Adenosis – – – NAT
L10 186 F 40 Breast Adenosis – – – NAT
L11 187 F 41 Breast Cancer adjacent breast tissue – – – NAT
L12 188 F 41 Breast Cancer adjacent breast tissue – – – NAT
L13 189 F 41 Breast Cancer adjacent breast tissue – – – NAT
L14 190 F 35 Breast Cancer adjacent breast tissue (sparse) – – – NAT
L15 191 F 35 Breast Cancer adjacent breast tissue – – – NAT
L16 192 F 35 Breast Cancer adjacent breast tissue – – – NAT
M1 193 F 35 Breast Cancer adjacent breast tissue (fibrofatty tissue and blood vessel) – – – NAT
M2 194 F 35 Breast Adenosis – – – NAT
M3 195 F 35 Breast Cancer adjacent breast tissue (fibrofatty tissue and blood vessel) – – – NAT
M4 196 F 46 Breast Adenosis – – – NAT
M5 197 F 46 Breast Cancer adjacent breast tissue – – – NAT
M6 198 F 46 Breast Cancer adjacent breast tissue – – – NAT
M7 199 F 55 Breast Cancer adjacent breast tissue – – – NAT
M8 200 F 55 Breast Cancer adjacent breast tissue (fibrofatty tissue and blood vessel) – – – NAT
M9 201 F 55 Breast Cancer adjacent breast tissue – – – NAT
M10 202 F 45 Breast Cancer adjacent breast tissue (hyalinosis of fibrous tissue and blood vessel) – – – NAT
M11 203 F 45 Breast Cancer adjacent breast tissue (hyalinosis of fibrous tissue and blood vessel) – – – NAT
M12 204 F 45 Breast Cancer adjacent breast tissue (hyalinosis of fibrous tissue and blood vessel) – – – NAT
M13 205 F 50 Breast Cancer adjacent breast tissue – – – NAT
M14 206 F 50 Breast Cancer adjacent breast tissue (fibrous tissue and blood vessel) – – – NAT
M15 207 F 50 Breast Cancer adjacent breast tissue – – – NAT
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイのFAQ

US BIOMAX社ヒト組織アレイのFAQはこちら。

目次に戻る

カートに商品を
追加しました。

お問い合わせ先

（テクニカルサポート 試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。

お問い合わせ先

（テクニカルサポート 試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。